Health Care Archives - Page 414 of 478

2 minute read

Why Analysts Love This High Yield Health Care Stock, Which Just Changed Its Name

September 13, 12:19 PM

Elevance Health Inc (NYSE: ELV) (previously known as Anthem) remains one of the leading health insurers in the U.S., providing medical benefits to roughly 45 million medical members.

ELV

1 minute read

Vaxxinity Starts Dosing In Phase 1 Migraine Vaccine Trial

By Vandana Singh

September 13, 11:58 AM

Vaxxinity Inc (NASDAQ:VAXX) announced that the first subjects had been dosed in the Phase 1 clinical trial of UB-313, a vaccine…

VAXX

1 minute read

Merck Secures Canadian Regulatory Nod For KEYTRUDA In Skin Cancer After Resection

By Ragothaman Srinivasan

September 13, 11:19 AM

Health Canada has granted approval for Merck’s (NYSE: MRK) KEYTRUDA (pembrolizumab) for the adjuvant treatment of adult and pediatric (12 years and older) patients with stage IIB or IIC melanoma following complete resection.

MRK

1 minute read

New GE-Backed Heart Disease Study May Advance Detection To Never Before Seen Levels

By Vandana Singh

September 13, 11:15 AM

GE Healthcare and Lantheus Holdings Inc (NASDAQ:LNTH) announced that the recent Phase 3 trial of a radiotracer, [18F]flurpiridaz, has met its co-primary…

LNTH

1 minute read

FDA Clears Akouos’ Gene Therapy Trial For Genetic Form Of Hearing Loss

By Vandana Singh

September 13, 9:53 AM

The FDA has signed off Akouos Inc’s (NASDAQ:AKUS) Investigational New Drug application to initiate a Phase 1/2 trial of AK-OTOF, gene…

AKUS

1 minute read

aTyr Pharma Gets FDA Fast Track Status For Systemic Sclerosis Candidate

By Ragothaman Srinivasan

September 13, 9:18 AM

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for aTyr Pharma’s (NASDAQ: LIFE) lead therapeutic candidate, efzofitimod, for the treatment of systemic sclerosis (SSc)-associated, interstitial lung disease (ILD).

LIFE

5 minute read

FDA Schedules AdComm Review For First Over The Counter Birth Control Pill

By Vandana Singh

September 13, 6:40 AM

The FDA has set a date to review what could become the first over-the-counter birth control pill approved in the…

PRGO

1 minute read

At R&D Day, Alpine Immune Highlights Updates On Autoimmune, Immuno-Oncology Programs

By Vandana Singh

September 13, 6:15 AM

Alpine Immune Sciences Inc (NASDAQ:ALPN) announced clinical updates from ALPN-303 and davoceticept programs. Key highlights from the announcement include: ALPN-303 Well…

ALPN

1 minute read

KKR’s A$14.5B Takeover Bid Of Australia’s Ramsay Health Care Hits A Snag

By Vandana Singh

September 13, 6:08 AM

Talks regarding KKR & Co (NYSE:KKR)-led consortium buying Australian hospital operator Ramsay Health Care Ltd (OTC:RMSYF) (OTC:RMYHY) have hit a snag. The consortium…

KKR